<ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>
    歡迎來到上海通蔚!

    021-54845833/15800441009

    品質保證 · 通蔚試劑

    當前位置: 首頁 > 科研產品 > 科研抗體 > 一抗 > 兔抗Fadd(Phospho-Ser191) 多克隆抗體

    產品中心

    • 兔抗Fadd(Phospho-Ser191) 多克隆抗體

      規(guī)格:
      價格:
      • 品牌 : 通蔚生物
      • 目錄號 : TW20184
      • 應用 : 僅供科研使用
      • 貨期 : 現貨
      • 規(guī)格 :100ul/200ul/25ul
    • 商品詳情
    • 參考文獻
    • 說明書下載
    • 商品評論0
    • 相關產品


    中文名稱:兔抗Fadd(Phospho-Ser191) 多克隆抗體 

    英文名稱: Anti-Fadd(Phospho-Ser191) rabbit polyclonal antibody

    別      名: GIG3; MORT1

    相關類別: 一抗

    儲      存: 冷凍(-20℃) 避光

    宿      主: Rabbit

    抗      原: Fadd(Phospho-Ser191)

    反應種屬: Human Mouse

    標  記 物: Unconjugate

    克隆類型: Unconjugate

    技術規(guī)格

    Background:

    The protein encoded by this gene is an adaptor molecule that interacts with various cell surface receptors and mediates cell apoptotic signals. Through its C-terminal death domain, this protein can be recruited by TNFRSF6/Fas-receptor, tumor necrosis factor receptor, TNFRSF25, and TNFSF10/TRAIL-receptor, and thus it participates in the death signaling initiated by these receptors. Interaction of this protein with the receptors unmasks the N-terminal effector domain of this protein, which allows it to recruit caspase-8, and thereby activate the cysteine protease cascade. Knockout studies in mice also suggest the importance of this protein in early T cell development. [provided by RefSeq, Jul 2008]

    Applications:

    WB, IHC

    Name of antibody:

    Fadd(Phospho-Ser191)

    Immunogen:

    Peptide sequence around phosphorylation site of Serine191(R-S-G(p)-A-M) derived from Human FADD.

    Full name:

    Fas (TNFRSF6)-associated via death domain

    Synonyms:

    GIG3; MORT1

    SwissProt:

    Q13158

    IHC positive control:

    Human breast carcinoma tissue

    IHC Recommend dilution:

    50-100

    WB Predicted band size:

    23 kDa

    WB Positive control:

    Jurkat cells lysates treated with PMA

    WB Recommended dilution:

    500-1000




    產品掃碼查看詳情
    手機掃描查看
    <ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>